Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2021 / Oct / Bitesize Breakthroughs
Research & Innovations Anterior Segment Cornea Retina

Bitesize Breakthroughs

The latest research from Translational Vision Science & Technology’s special regenerative medicine issue

By Geoffrey Potjewyd 10/12/2021 1 min read

Share

Eye of newt, toe of frog

Full lens regeneration is an amazing ability of our closest regenerative relatives – newts, frogs, and axolotls  – with newts retaining this ability throughout their lives. The process can now be tracked in vivo using OCT, giving unique insights into cellular and morphological events and taking us closer to unlocking the newt’s regenerative secrets (1).

Freezer fresh

A recent study shows that cryopreserved bone marrow stromal cells (BMSCs) are safe and effective for subconjunctival injection to promote corneal epithelial wound healing in animal models (2). BMSCs are used in cell-based therapies to aid regeneration, and both in vitro and in vivo experiments demonstrated significantly increased wound healing. This study exhibits preclinical safety for conjunctival administration before a phase I clinical trial in humans.

See again

Voretigene neparvovec has been used successfully for the first time in two Italian pediatric patients with inherited retinal dystrophy (RPE65-IRD). Significant increases in visual function occurred in both patients – even following surgical complications in one (3). These results correlate with the results of previous clinical trials.

Bionic eyes

A real-world assessment reveals a positive impact on functional vision from implantation of a second-generation (44-channel) suprachoroidal retinal prosthesis in patients with late-stage retinitis pigmentosa (4). The implant allows for artificial ultra-low vision that can detect shapes, movement, and light. Further research will focus on more patients to increase statistical power.

The sound of regeneration

In vivo tracking of transplanted cells can be performed using photoacoustic imaging combined with OCT and fluorescent imaging. Researchers tracked transplanted human retinal pigment epithelial cells (ARPE-19) tagged with ICG dye, recording cell location, viability, and layer thickness (5). The tracking enables nondestructive monitoring of the distribution, fate, and function of cell therapies.

References

  1. W Chen et al., Transl Vis Sci Technol, 10, 4 (2021). PMID: 34383878.
  2. I Putra et al., Transl Vis Sci Technol, 10, 3 (2021). PMID: 34383879.
  3. F Testa et al., Transl Vis Sci Technol, 10, 11 (2021). PMID: 34554209.
  4. L Karapanos et al., Transl Vis Sci Technol, 10, 7 (2021). PMID: 34383875.
  5. VP Nguyen et al., Transl Vis Sci Technol, 10, 10 (2021). PMID: 34473239.

About the Author(s)

Geoffrey Potjewyd

The lion’s share of my PhD was spent in the lab, and though I mostly enjoyed it (mostly), what I particularly liked was the opportunity to learn about the latest breakthroughs in research. Communicating science to a wider audience allows me to scratch that itch without working all week only to find my stem cell culture has given up the ghost on the Friday (I’m not bitter). Fortunately for me, it turns out writing is actually fun – so by working for Texere I get to do it every day, whilst still being an active member of the clinical and research community.

More Articles by Geoffrey Potjewyd

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: